IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,105,979 | -8.3% | 3,913,410 | +5.9% | 0.04% | -2.4% |
| Q2 2023 | $221,581,580 | +32.8% | 3,695,490 | +9.5% | 0.04% | +27.3% |
| Q1 2023 | $166,875,278 | +35.8% | 3,375,309 | +56.8% | 0.03% | +32.0% |
| Q4 2022 | $122,869,769 | +287.9% | 2,152,966 | +219.1% | 0.02% | +257.1% |
| Q3 2022 | $31,672,000 | -32.9% | 674,733 | -46.7% | 0.01% | -30.0% |
| Q2 2022 | $47,230,000 | +17.7% | 1,265,912 | -5.7% | 0.01% | +42.9% |
| Q1 2022 | $40,136,000 | -17.1% | 1,342,359 | -5.1% | 0.01% | -12.5% |
| Q4 2021 | $48,420,000 | +24.2% | 1,414,150 | +34.4% | 0.01% | +14.3% |
| Q3 2021 | $39,000,000 | +242.6% | 1,052,075 | +260.9% | 0.01% | +250.0% |
| Q2 2021 | $11,383,000 | +8.1% | 291,512 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $10,530,000 | – | 247,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |